We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Multi-Year Contract Extension with Nycomed for Genedata Screener
News

Multi-Year Contract Extension with Nycomed for Genedata Screener

Multi-Year Contract Extension with Nycomed for Genedata Screener
News

Multi-Year Contract Extension with Nycomed for Genedata Screener

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Multi-Year Contract Extension with Nycomed for Genedata Screener"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genedata has announced a multi-year contract extension for the use of the Genedata Screener® discovery product suite with Nycomed. Taking a trusted collaboration to the next level, Genedata will create a global scientific computing infrastructure for the lead discovery and drug research programs at Nycomed sites worldwide.

Independent of instrumentation, technology, volume or location, Genedata Screener will enable the interdisciplinary teams at all sites to capture, visualize, analyze and manage large volumes of assay data. Low to ultra-high throughput screens, single-point assays or complex high content screens will all benefit from Screener`s high performance and flexibility.

The combination of these findings with data from other corporate sources, accessible through Screener`s powerful viewing tools, will provide Nycomed scientists with the range of information they need to enhance their lead finding processes – anywhere on the globe.

Dr. Werner Stürmer, Head of HTS at Nycomed, explained, “Genedata Screener not only improves the efficiency and quality of our screening campaigns, but also has a catalytic impact on our global information network – increasing the number of users and promoting accurate and timely decisions across departments and countries."

Dr. Stephan Heyse, Head of the Genedata Screener Business Unit, added, “Our high performance and advanced quality control capabilities together with the established professional services and low maintenance cost will help to ease time constraints and to streamline communication, while generating high-quality results.”

Advertisement